Gastrointestinal stromal tumour

H Joensuu, P Hohenberger, CL Corless - The Lancet, 2013 - thelancet.com
Gastrointestinal stromal tumours (GISTs) are mesenchymal neoplasms that arise in the
gastrointestinal tract, usually in the stomach or the small intestine and rarely elsewhere in …

Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts

H Joensuu, A Vehtari, J Riihimäki, T Nishida… - The lancet …, 2012 - thelancet.com
Background The risk of recurrence of gastrointestinal stromal tumour (GIST) after surgery
needs to be estimated when considering adjuvant systemic therapy. We assessed …

Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up

PG Casali, JY Blay, N Abecassis, J Bajpai, S Bauer… - Annals of oncology, 2022 - Elsevier
Highlights•This clinical practice guideline provides key recommendations on the
management of gastrointestinal stromal tumours.•Recommendations have been agreed …

Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial

CL Corless, KV Ballman, CR Antonescu… - Journal of Clinical …, 2014 - ascopubs.org
Purpose The ACOSOG (American College of Surgeons Oncology Group) Z9001 (Alliance)
study, a randomized, placebo-controlled trial, demonstrated that 1 year of adjuvant imatinib …

[HTML][HTML] Prognostic indicators for gastrointestinal stromal tumors: a review

H Zhang, Q Liu - Translational Oncology, 2020 - Elsevier
Gastrointestinal stromal tumors (GISTs) are potentially malignancies that can occur
anywhere in the digestive tract. Tyrosine kinase inhibitors (TKIs) such as imatinib have …

Tumor genotype is an independent prognostic factor in primary gastrointestinal stromal tumors of gastric origin: a European multicenter analysis based on …

A Wozniak, P Rutkowski, P Schöffski… - Clinical cancer …, 2014 - AACR
Purpose: Although the mutational status in gastrointestinal stromal tumors (GIST) can predict
the response to treatment with tyrosine kinase inhibitors, the role of tumor genotype as a …

Molecular subtypes of gastrointestinal stromal tumors and their prognostic and therapeutic implications

Z Szucs, K Thway, C Fisher, R Bulusu… - Future …, 2017 - Taylor & Francis
Gastrointestinal stromal tumors (GISTs) are composed of various molecular subtypes, with
differing prognostic and predictive relevance. Previously, tumors lacking mutations in the KIT …

Update on molecular genetics of gastrointestinal stromal tumors

I Brčić, A Argyropoulos, B Liegl-Atzwanger - Diagnostics, 2021 - mdpi.com
Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the
gastrointestinal tract. The majority are sporadic, solitary tumors that harbor mutually …

Long-term results of adjuvant imatinib mesylate in localized, high-risk, primary gastrointestinal stromal tumor: ACOSOG Z9000 (Alliance) intergroup phase 2 trial

RP DeMatteo, KV Ballman, CR Antonescu… - Annals of …, 2013 - journals.lww.com
Objective: To conduct the first adjuvant trial of imatinib mesylate for treatment of
gastrointestinal stromal tumor (GIST). Background: GIST is the most common sarcoma …

Correlation of CT radiomic features for GISTs with pathological classification and molecular subtypes: Preliminary and monocentric experience

D Palatresi, F Fedeli, G Danti, E Pasqualini… - La radiologia …, 2022 - Springer
Purpose Our primary purpose was to search for computed tomography (CT) radiomic
features of gastrointestinal stromal tumors (GISTs) that could potentially correlate with the …